Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a new way in which RAS genes, ...
Mabel Mardones, MD, Rocky Mountain Cancer Centers, discusses the future of HR+/HER2– breast cancer treatment, focusing on the importance of biomarkers and the potential of SIRDs to improve patient ...